Cytokinetics, Incorporated Blog | Talkmarkets

Latest Posts

Cytokinetics Announces Pricing Of Public Offering Of Common Stock

Article By: NASDAQ GlobeNewswire

Thursday, July 16, 2020 7:15 PM EDT

Cytokinetics, Incorporated today announced the pricing of an underwritten public offering of 7,291,667 shares of its common stock at a price to the public of $24.00 per share, before underwriting discounts and commissions.

In this article: CYTK

Read

5 Tiny Biotech Stocks With Superb Growth Potential

Article By: Swarup Gupta

Wednesday, February 13, 2019 11:40 AM EDT

After a disastrous end to 2018, pharma stocks have started the New Year on a considerably strong note. Here are several biotech stocks which would be a smart choice to invest in.

In this article: BDSI, CYTK, CLDX, ADRO, AEZS Also: XBI, BMY, CELG, LLY, LOXO

Read

3 Biotechs With Upcoming Data To Be Presented At Conferences

Article By: Scott Matusow

Tuesday, June 12, 2018 5:24 AM EDT

Biotech stocks tend to have strong movement when their respective companies have binary events upcoming in short order. Here are 3 companies with upcoming data to be presented at data conferences this week.

In this article: CYTK, ARQL, AFMD Also: MYOK, AZN

Read

Update On Currently Recommended Stocks

Article By: SmithOnStocks

Monday, September 25, 2017 4:19 PM EDT

In this report I update my objectives and include several buy recommendations in the biotech sphere.

In this article: CYTK, AIS, NWBO, PTLA, RGEN, CYRX, BMY, ALIM, AGEN, EYPT, AMAG, WINT, AMGN, GNE, BIIB

Read

Cytokinetics: Reiteration Of My Long Standing Buy Recommendation Based On An Extraordinary Pipeline

Article By: SmithOnStocks

Monday, August 7, 2017 5:01 PM EDT

CYTK reported a loss of $29 million in the second quarter and currently has a $332 million cash position which management indicates can carry the Company through 2H, 2019.

In this article: CYTK

Read

All Posts